TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL June 11, 2014
TCL Archive Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease November 30, 2012
TCL Archive Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women November 26, 2010
TCL Archive ESAs Increase Risk of Death by 11 Percent, Blood Clots by 59 Percent, Meta-Analysis Finds; Study To Be Updated At ASCO. June 1, 2007
